New Drug Targets Bone Disease That Causes Hearing Loss
The drug LGK974, which inhibits the Wnt signaling pathway, shows promise in reversing excessive bone growth in sclerosteosis.
The drug LGK974, which inhibits the Wnt signaling pathway, shows promise in reversing excessive bone growth in sclerosteosis.
Federal funding cuts to hearing health programs and research threaten innovation, access, and outcomes in audiology care, with especially dire consequences for vulnerable populations and early childhood intervention.
Birdsong Hearing Benefits has launched Harmony, a next-generation hearing aid designed to deliver superior sound, comfort, and accessibility, aiming to improve hearing health outcomes and bridge the gap in hearing aid adoption.
A new review highlights the underrecognized potential of vaccines to prevent childhood hearing loss, especially in low- and middle-income countries.
Interacoustics' Equinox Evo and Touch Keyboard provide an intuitive audiometric solution designed to enhance clinical workflows and patient engagement for audiologists.
Blueprint Solutions is launching a major update to its OMS platform, incorporating advanced AI features and a new text messaging center to boost practice efficiency and enhance patient communication.